Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Neuronetics Inc STIM

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a... see more

Opinion & Analysis (NDAQ:STIM)

No current opinion is available.

Bullboard Posts (NDAQ:STIM)

Investing in mental health: a rising imperative

As of July 2025, Neuronetics' stock is trading at $3.66 USD, with analysts forecasting a potential upside to between $6.50 and $7.50...
6thDimension - July 21, 2025

Neuronetics (STIM): Revolutionizing Neurohealth with Cutting

Interesting play in the neurohealth space. STIM has been grinding it out with their NeuroStar system and looks like they're making...
MikeTester - January 24, 2025

This stock is a good buy at these low prices and

It looks like an uptrend is starting to develop for this one.
coolfooldumbguy - January 13, 2025

$STIM Climbs Post-Earnings as $MYNZ Offers a Buying Opportun

$STIM continues its steady climb following last week’s earnings report, posting a +16% gain today. Keeping an eye on $MYNZ, which I’ve...
WealthLine48 - November 26, 2024

$STIM Climbs Post-Earnings as $MYNZ Offers a Buying Opportun

$STIM continues its steady climb following last week’s earnings report, posting a +16% gain today. Keeping an eye on $MYNZ, which I’ve...
Trader19Swift - November 26, 2024

Neuronetics, Inc. (NASDAQ:STIM): Innovative Neurohealth Solu

http://beyondspx.com/2024/08/02/neuronetics-inc-nasdaqstim-innovative-neurohealth-solutions-driving-sustainable-growth/
MikeTester - August 3, 2024

Podcasts